| Product NDC: | 0378-8700 |
| Proprietary Name: | Acyclovir |
| Non Proprietary Name: | acyclovir |
| Active Ingredient(s): | 50 mg/g & nbsp; acyclovir |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0378-8700 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202459 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130507 |
| Package NDC: | 0378-8700-06 |
| Package Description: | 1 TUBE in 1 CARTON (0378-8700-06) > 15 g in 1 TUBE |
| NDC Code | 0378-8700-06 |
| Proprietary Name | Acyclovir |
| Package Description | 1 TUBE in 1 CARTON (0378-8700-06) > 15 g in 1 TUBE |
| Product NDC | 0378-8700 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | acyclovir |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20130507 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | ACYCLOVIR |
| Strength Number | 50 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |